NCT03988855
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 2, 2019
Completion: Dec 31, 2022